A new study reveals head impact, not concussion, triggers CTE. The discovery could help with early detection and treatments for the neurodegenerative disorder.
A molecular process caused by the TREM2 gene mutation in the brain's microglia increases the risk of Alzheimer's disease, a new study reports.
The P522R gene variant increases expression levels of several microglia genes which are reduced in people with Alzheimer's disease.
Researchers have identified a biomarker that is associated with the activation of an innate immune response to neural damage during the early stages of Alzheimer's disease.
Researchers have developed a new technique to measure levels of amyloid beta in the brain. They have also discovered new insights into why mutations of the TREM2 gene increases the risk of developing Alzheimer's disease.
Having a sedentary lifestyle and eating a western diet is linked to an increased risk of developing Alzheimer's disease, a new study reports.
DHA treatment reduced the size of the damaged brain area and initiated a repair mechanism in animal models of stroke. DHA affected the levels of MANF and TREM2, two proteins critical for communication between brain cells.
According to a new study, triggering TREM2 could help slow the progression of some neurodegenerative diseases.
A new study investigates how genetics risk factors for Alzheimer's could influence a key immune cell.
Researchers have discovered an early immune response in people with a genetic predisposition to Alzheimer's disease.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
Study in mice and humans reveals reinforcing the activity of microglia could slow, or potentially halt, the proliferation of Tau tangles in Alzheimer's disease.
